Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taylor M Parker

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Seminars in Cancer Biology|September 13, 2019
Cell competition and tumor heterogeneityTaylor M Parker, Vanessa Henriques, Antonio Beltran, et al.
Canadian Journal of Physiology and Pharmacology|January 17, 2017
Clinical use of high mobility group box 1 and the receptor for advanced glycation end products in the prognosis and risk stratification of heart failure: a literature reviewAmanda M Marsh, Austin Huy Nguyen, Taylor M Parker, et al.
Brain Injury|November 8, 2016
The danger zone: Systematic review of the role of HMGB1 danger signalling in traumatic brain injuryTaylor M Parker, Austin Huy Nguyen, Joshua R Rabang, et al.
Oncogene|January 9, 2021
Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expressionDuojiao Chen, Taylor M Parker, Poornima Bhat-Nakshatri, et al.
The EMBO Journal|August 9, 2021
Cell competition in intratumoral and tumor microenvironment interactionsTaylor M Parker, Kartik Gupta, António M Palma, et al.
International Journal of Molecular Sciences|December 29, 2016
Development of Orally Administered γ-Tocotrienol (GT3) Nanoemulsion for RadioprotectionGrace A Ledet, Shukla Biswas, Vidya P Kumar, et al.
Nucleic Acids Research|September 21, 2019
HIF-transcribed p53 chaperones HIF-1αEsha Madan, Taylor M Parker, Christopher J Pelham, et al.
The Journal of Biological Chemistry|February 1, 2018
The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53Esha Madan, Taylor M Parker, Matthias R Bauer, et al.
Nature|July 26, 2019
Flower isoforms promote competitive growth in cancerEsha Madan, Christopher J Pelham, Masaki Nagane, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Cancer Biology|September 13, 2019
Cell competition and tumor heterogeneityTaylor M Parker, Vanessa Henriques, Antonio Beltran, et al.
Canadian Journal of Physiology and Pharmacology|January 17, 2017
Clinical use of high mobility group box 1 and the receptor for advanced glycation end products in the prognosis and risk stratification of heart failure: a literature reviewAmanda M Marsh, Austin Huy Nguyen, Taylor M Parker, et al.
Brain Injury|November 8, 2016
The danger zone: Systematic review of the role of HMGB1 danger signalling in traumatic brain injuryTaylor M Parker, Austin Huy Nguyen, Joshua R Rabang, et al.
Oncogene|January 9, 2021
Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expressionDuojiao Chen, Taylor M Parker, Poornima Bhat-Nakshatri, et al.
The EMBO Journal|August 9, 2021
Cell competition in intratumoral and tumor microenvironment interactionsTaylor M Parker, Kartik Gupta, António M Palma, et al.
International Journal of Molecular Sciences|December 29, 2016
Development of Orally Administered γ-Tocotrienol (GT3) Nanoemulsion for RadioprotectionGrace A Ledet, Shukla Biswas, Vidya P Kumar, et al.
Nucleic Acids Research|September 21, 2019
HIF-transcribed p53 chaperones HIF-1αEsha Madan, Taylor M Parker, Christopher J Pelham, et al.
The Journal of Biological Chemistry|February 1, 2018
The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53Esha Madan, Taylor M Parker, Matthias R Bauer, et al.
Nature|July 26, 2019
Flower isoforms promote competitive growth in cancerEsha Madan, Christopher J Pelham, Masaki Nagane, et al.
Pageof 1